À̺¥Æ® ¼Ò°³

2025³â PEGS Boston SummitÀº ¹ÙÀÌ¿À·ÎÁ÷½º¡¤´Ü¹éÁú ¿£Áö´Ï¾î¸µÀÇ ÁÖ·Â À̺¥Æ®·Î¼­ÀÇ ÁöÀ§¸¦ À¯ÁöÇϸ鼭 °ú°ÅÀÇ ¼º°øÀ» ¶Ù¾î³Ñ°í ÀÖ½À´Ï´Ù. Àü¹®°¡, À̳뺣ÀÌÅÍ, ±Û·Î¹ú ¸®´õ°¡ ÇÑÀÚ¸®¿¡ ¸ð¿© ÀǰßÀ» ±³È¯Çϰí, ±³·ùÇÏ´Â Àå¼ÒÀÔ´Ï´Ù!

¾÷°è¿¡¼­ °¡Àå ¿µÇâ·Â ÀÖ°í, »ý°¢À» ÀÚ±ØÇÏ´Â ¿¬»çÀÇ À̾߱⸦ µéÀ» ¼ö ÀÖ½À´Ï´Ù.

  • ÁÖ¿ä ¿¬±¸ÀÚ ¹× »ç°í ¸®´õ 350¸íÀÌ Çõ½ÅÀûÀÎ ÇÁ·¹Á¨Å×ÀÌ¼Ç ¹× »ç·Ê ¿¬±¸¸¦ °øÀ¯Çϰí, ÆÐ³Î µð½ºÄ¿¼ÇÀ» ÁÖµµÇϰí, ÀÎÅÍ·¢Æ¼ºê ºê·¹ÀÌÅ©¾Æ¿ô µð½ºÄ¿¼ÇÀ» ÁøÇàÇÕ´Ï´Ù.
  • ÁÖ¿ä Å×Å©³î·¯Áö ÇÁ·Î¹ÙÀÌ´õ ¹× ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡ ÀÇÇÑ ½ºÆù¼­ Á¦°ø °­¿¬¿¡¼­´Â ÃÖ÷´Ü Å×Å©³î·¯Áö ¹× ½Å»óǰ µîÀÌ ¼Ò°³µË´Ï´Ù.

»õ·Î¿î Àü·«, ÃֽŠÇõ½Å Å×Å©³î·¯Áö, º£½ºÆ® ÇÁ·¢Æ¼½º¿¡ °üÇÑ ÀλçÀÌÆ®¸¦ ¾ò°í, ÀÚ½ÅÀÇ ¿¬±¸¸¦ ´ÙÀ½ ·¹º§·Î ÁøÇàÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ´Ü¹éÁú¡¤Ç×ü °øÇÐ, ÀÌÁ߯¯À̼ºÇ×ü °³¹ß, ¹ÙÀÌ¿À·ÎÁ÷½ºÀÇ Æ¯¼º Æò°¡, ´Ü¹éÁú ¹ßÇö Ç÷§Æû, AI/ML µå¸®ºì ¹ÙÀÌ¿À·ÎÁ÷½º ¿¬±¸ µî 20°³ÀÇ ÄÁÆÛ·±½º ÇÁ·Î±×·¥°ú Æ®·¹ÀÌ´× ¼¼¹Ì³ª¿¡¼­ »ó¼¼ÇÏ°Ô ¼³¸íÇÕ´Ï´Ù.
  • ÀÎÅÍ·¢Æ¼ºê ºê·¹ÀÌÅ©¾Æ¿ô ¼¼¼Ç¿¡¼­´Â ÃËÁøµÈ ¼Ò±×·ì µð½ºÄ¿¼ÇÀ» ÁøÇàÇÕ´Ï´Ù.
  • µî·Ï ¿É¼Ç¿¡ ÀÇÇØ ¿©·¯ºÐÀÇ ½ºÄÉÁÙ ¹× ¿¬±¸ ¸ñÇ¥¿¡ ¸ÂÃß¾î ±³À° ¹× ³×Æ®¿öÅ· ¾ÆÁ¨´Ù¸¦ Ä¿½ºÅ͸¶ÀÌÁîÇÒ ¼ö ÀÖ½À´Ï´Ù.


¼¼°èÀÇ »ç°í ¸®´õ¿Í ¿¬°áµÇ°í, µ¿·á¿Í Çù¾÷Çϰí, ³×Æ®¿öÅ©¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ¹ÙÀÌ¿ÀÀǾàǰÀÇ Áøº¸¿¡¼­ÀÇ °úÁ¦¿Í ±âȸ¿¡ ÃÊÁ¡À» ¸ÂÃß°í, Àü ¼¼°èÀÇ ¿¬±¸ÀÚ¿Í ±³·ùÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • µµÂøÇϱâ ÀüºÎÅÍ ´ëÈ­¸¦ ½ÃÀÛÇսôÙ! µðÁöÅÐ Ç÷§Æû¿¡ ÀÇÇØ °°Àº Èï¹Ì³ª ¸ñÇ¥¸¦ °¡Áø Âü°¡ÀÚ¿Í ¿¬°áµÉ ¼ö ÀÖ½À´Ï´Ù.
  • Ä¿¹Â´ÏƼ¿¡ Âü°¡ÇսôÙ! LinkedIn ¹× X¿¡¼­ #PEGSummitÀ» ÆÈ·Î¿ìÇϼ¼¿ä.
  • µ¿½Ã °³ÃÖ ÄÁÆÛ·±½º ÇÁ·Î±×·¥ °£ 'Æ®·¢ È£ÇÎ'¿¡ ÀÇÇØ ¿©·¯ºÐÀÇ °æÇèÀ» Ä¿½ºÅ͸¶ÀÌÁîÇÒ ¼ö ÀÖ½À´Ï´Ù.


ÇØ´ç ÄÁÆÛ·±½º´Â Á¾·áµÇ¾ú½À´Ï´Ù.
Choose your language
Traditional Chinese
Simplified Chinese
Japanese
English_


Ç¥½ÃÇϱâ:

Engineering
°øÇÐ ½ºÆ®¸²
  • Display of Biologics
    ¹ÙÀÌ¿À·ÎÁ÷½ºÀÇ µð½ºÇ÷¹ÀÌ
  • Engineering Antibodies
    Ç×ü °øÇÐ
  • Machine Learning for Protein Engineering
    ´Ü¹éÁú ¿£Áö´Ï¾î¸µ¿ë ±â°èÇнÀ
Oncology
Á¾¾ç ½ºÆ®¸²
  • Antibodies for Cancer Therapy
    ¾ÏÄ¡·á¿ë Ç×ü
  • Emerging Targets for Oncology & Beyond
    Á¾¾ç ÀÌ¿Ü ½Å±Ô Ÿ±ê
  • Driving Clinical Success in Antibody-Drug Conjugates
    Ç×ü¾à¹°Á¢ÇÕü(ADC)ÀÇ ÀÓ»óÀû ¼º°øÀÇ ÃßÁø
Bispecific Antibodies
´ÙÁ߯¯À̼º ½ºÆ®¸²
Immunotherpary
¸é¿ªÄ¡·á ½ºÆ®¸²
  • Advances in Immunotherapy
    ¸é¿ªÄ¡·áÀÇ Áøº¸
  • Engineering Cell Therapies
    ¼¼Æ÷Ä¡·á °øÇÐ
  • Next-Generation Immunotherapies
    Â÷¼¼´ë ¸é¿ªÄ¡·á
Expression
¹ßÇö ½ºÆ®¸²
  • Difficult-to-Express Proteins
    ¹ßÇöÀÌ ¾î·Á¿î ´Ü¹éÁú
  • Optimizing Protein Expression
    ´Ü¹éÁú ¹ßÇöÀÇ ÃÖÀûÈ­
  • Maximizing Protein Production Workflows
    ´Ü¹éÁú »ý»ê ¿öÅ©Ç÷οìÀÇ ÃÖ´ëÈ­
Analytical
ºÐ¼®¹ý ½ºÆ®¸²
  • ML and Digital Integration in Biotherapeutic Analytics
    ¹ÙÀÌ¿ÀÀǾàǰ ºÐ¼®¿¡¼­ ML°ú µðÁöÅÐ ÅëÇÕ
  • Biophysical Methods
    »ý¹°¹°¸®ÇÐÀû ¹æ¹ý
  • Characterization for Novel Biotherapeutics
    ½Å±Ô ¹ÙÀÌ¿ÀÀǾàǰÀÇ Æ¯¼º Æò°¡
Immunogenicity
¸é¿ª¿ø¼º ½ºÆ®¸²
Emerging Modalities
½Å±Ô Ä¡·á ½ºÆ®¸²
  • Biologics for Immunology Indications
    ÀûÀÀ ¸é¿ª¿ë ¹ÙÀÌ¿À·ÎÁ÷½º
  • Radiopharmaceutical Therapies
    ¹æ»ç¼º ÀǾàǰ Ä¡·á
  • Next-Generation Immunotherapies
    Â÷¼¼´ë ¸é¿ªÄ¡·á
Machine Learning Stream
±â°èÇнÀ ½ºÆ®¸²
  • ML and Digital Integration in Biotherapeutic Analytics
    ¹ÙÀÌ¿ÀÀǾàǰ ºÐ¼®¿¡¼­ ML°ú µðÁöÅÐ ÅëÇÕ
  • Predicting Immunogenicity with AI/ML Tools
    AI/ML Åø¿¡ ÀÇÇÑ ¸é¿ª¿ø¼º ¿¹Ãø
  • Machine Learning for Protein Engineering
    ´Ü¹éÁú ¿£Áö´Ï¾î¸µ¿ë ±â°èÇнÀ

Premier Sponsors

FairJourneyBiologics GenScript-CRO Integral-Molecular_NEW  LONZAOmniAbUnchainedLabs
Catalog Download
Catalog